Executives On The Move: Five Prime Fills Its CFO Slot, Myovant Appoints Chief Commercial Officer and Onconova Adds a CMO, R&D
Executive Summary
Immuno-oncology treatment developer Five Prime Therapeutics hires a CFO, while Myovant Sciences, focused on women’s health and endocrine disease, appoints a chief commercial officer. And Onconova Therapeutics boosts its drug development expertise with addition of new CMO, R&D.